Stromelysin-3 expression: an independent prognostic marker in node positive breast carcinoma

被引：0
|
作者：
Ahmad, A
Hanby, AM
Dublin, EA
Bassett, P
Hart, IR
机构：
[1] UMDS, St Thomas Hosp, Imperial Canc Res Fund, Richard Dimbleby Dept, London SE1 7EH, England
[2] Guys Hosp, Imperial Canc Res Fund, Hedley Atkins Pathol Lab, London SE1 9RT, England
[3] ULP, Inst Genet & Biol Mol, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France
来源：
JOURNAL OF PATHOLOGY | 1998年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：23A / 23A
页数：1
相关论文
共 50 条
  • [41] The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients
    Parker, Catherine C.
    Kim, Roger H.
    Li, Benjamin D. L.
    Chu, Quyen D.
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (04) : 393 - 398
  • [42] A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum
    Janusz Wlodarczyk
    Birgit Bethke
    Elke Mueller
    Manfred Stolte
    James Mueller
    Virchows Archiv, 2001, 439 : 756 - 761
  • [43] A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum
    Wlodarczyk, J
    Bethke, B
    Mueller, E
    Stolte, M
    Mueller, J
    VIRCHOWS ARCHIV, 2001, 439 (06) : 756 - 761
  • [44] Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction
    Wang, CS
    Têtu, B
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (06) : 792 - 799
  • [45] STROMELYSIN-3 BELONGS TO A SUBGROUP OF PROTEINASES EXPRESSED IN BREAST-CARCINOMA FIBROBLASTIC CELLS AND POSSIBLY IMPLICATED IN TUMOR PROGRESSION
    WOLF, C
    ROUYER, N
    LUTZ, Y
    ADIDA, C
    LORIOT, M
    BELLOCQ, JP
    CHAMBON, P
    BASSET, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1843 - 1847
  • [46] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielson, TO
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2005, 18 : 53A - 53A
  • [47] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielsen, TO
    Gilks, CB
    Huntsman, DG
    LABORATORY INVESTIGATION, 2005, 85 : 53A - 53A
  • [48] CA 15-3 is an independent pre-operative prognostic marker in breast carcinoma
    Irish Journal of Medical Science, 2001, 170 (Suppl 1)
  • [49] Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential
    Mueller, J
    Breback, B
    Schmalfeldt, B
    Kuhn, W
    Graeff, H
    Höfler, H
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2000, 437 (06): : 618 - 624
  • [50] TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
    Overgaard, J
    Yilmaz, M
    Guldberg, P
    Hansen, LL
    Alsner, J
    ACTA ONCOLOGICA, 2000, 39 (03) : 327 - 333
12345